Merck scraps another late-stage Alzheimer's drug study

NEW YORK (Reuters) - Merck& Co Inc on Tuesday said it will end another late-stage trial of an Alzheimer's drug because it was unlikely to work, adding to the pile-up of failures to find an effective treatment for the mind-wasting disease.

Source: Reuters: Health - February 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news